NOT KNOWN FACTUAL STATEMENTS ABOUT MODAFINIL NORGE

In people who are deficient in CYP2D6, coadministration of modafinil with substrates of CYP2D6 which have ancillary routes of elimination by means of CYP2C19 (eg, tricyclic antidepressants and selective serotonin reuptake inhibitors) may well lead to elevated circulating levels of these drugs and demand dose adjustment (Robertson et al 2000; PROVIG